Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Victoza
Victoza
More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tue, 09/9/14 - 08:08 am
obesity
Orexigen
Novo Nordisk
NB32
liraglutide
Victoza
Takeda
Novo Nordisk diabetes drug appears effective for weight loss -study
Yahoo/Reuters
Sun, 06/15/14 - 10:44 am
Novo Nordisk
obesity
diabetes
Victoza
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Fierce Biotech
Mon, 06/9/14 - 01:21 pm
Victoza
Eli Lilly
diabetes
dulaglutide
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Seeking Alpha
Wed, 04/16/14 - 09:37 am
Lyxumia
GLP-1 agonist
Sanofi
Novo Nordisk
diabetes
Victoza
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
diabetes
Takeda
Sanofi
GSK
Victoza
Merck
insulin
Novo Nordisk
Afrezza
U300
Tresiba
Eli Lilly
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
Thu, 02/27/14 - 08:19 am
FDA
diabetes
Merck
Januvia
Janumet
Novo Nordisk
Victoza
Bristol-Myers Squibb
Byetta
Bydureon
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:03 pm
Victoza
Novo Nordisk
Eli Lilly
dulaglutide
diabetes
Bydureon
AstraZeneca
Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tue, 02/25/14 - 08:15 am
Eli Lilly
diabetes
Victoza
Novo Nordisk
dulaglutide
Will These Drugmakers Profit From Patient Weight Loss?
Motley Fool
Wed, 12/4/13 - 03:47 pm
obesity
Victoza
Novo Nordisk
Contrave
Orexigen
Vivus
Qsymia
This Diabetes Giant Could Face 3 Major Challenges
Motley Fool
Tue, 11/5/13 - 09:57 am
diabetes
Novo Nordisk
Tresiba
GLP-1 agonist
Victoza
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Could This Popular Diabetes Treatment Also Treat Alzheimer's Disease?
Motley Fool
Thu, 09/26/13 - 02:50 pm
Alzheimer's disease
diabetes
Novo Nordisk
Victoza
Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wed, 09/25/13 - 10:35 am
Novo Nordisk
Victoza
diabetes
Is This Diabetes Drug Stock in Jeopardy?
Motley Fool
Sun, 09/15/13 - 12:25 pm
Novo Nordisk
Victoza
diabetes
type 2 diabetes
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Bloomberg
Fri, 08/16/13 - 10:42 am
insulin
diabetes
Sanofi
Novo Nordisk
Levemir
Lantus
Victoza
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »